Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-21-030429)

Filing Details

Accession Number:: 0001213900-21-030429
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-02 12:19:14
Reporting Period:: 2021-06-01

Accepted Time:: 2021-06-02 12:19:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1726711	Aditx Therapeutics Inc.	ADTX	Pharmaceutical Preparations (2834)	823204328

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818598	Rowena Albanna	C/O Aditx Therapeutics, Inc. 2569 Wyandotte St., Suite 101 Mountain View CA 94043	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-01	500	$2.93	748,720	No	4	P	Indirect	By husband
Common Stock	Acquisiton	2021-06-01	1,000	$2.95	749,720	No	4	P	Indirect	By husband
Common Stock	Acquisiton	2021-06-01	1,000	$2.95	750,720	No	4	P	Indirect	By husband
Common Stock	Acquisiton	2021-06-01	800	$2.90	751,520	No	4	P	Indirect	By husband
Common Stock	Acquisiton	2021-06-01	100	$2.89	751,620	No	4	P	Indirect	By husband

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By husband
No	4	P	Indirect	By husband
No	4	P	Indirect	By husband
No	4	P	Indirect	By husband
No	4	P	Indirect	By husband